1st Global Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-2,950
Closed -$1.19M – 449
2015
Q2
$1.19M Buy
2,950
+6
+0.2% +$2.41K 0.18% 80
2015
Q1
$1.24M Sell
2,944
-131
-4% -$51.6K 0.18% 78
2014
Q4
$1.04M Buy
3,075
+126
+4% +$40.8K 0.15% 87
2014
Q3
$976K Sell
2,949
-34
-1% -$11.2K 0.15% 85
2014
Q2
$941K Buy
2,983
+707
+31% +$213K 0.14% 94
2014
Q1
$696K Sell
2,276
-56
-2% -$17.8K 0.13% 119
2013
Q4
$652K Sell
2,332
-854
-27% -$221K 0.12% 120
2013
Q3
$767K Buy
3,186
+494
+18% +$111K 0.16% 91
2013
Q2
$579K Buy
+2,692
New +$575K 0.13% 107

Other funds holding BIIB

1st Global Advisors's BIIB Position: Q3 2015 in Review

1st Global Advisors sold out of Biogen (BIIB) in Q3 2015, closing a stake of 2,950 shares — an estimated $1.19M sold.

1st Global Advisors first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.24M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • 1st Global Advisors reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • 1st Global Advisors sold 2,950 Biogen shares in Q3 2015, an estimated $1.19M.
  • 1st Global Advisors first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • 1st Global Advisors's Biogen position peaked at $1.24M in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on 1st Global Advisors's 13F filing for Q3 2015, filed 21 Oct 2015.